Teva Pharmaceutical Industries (FRA:TEV) Dividend Yield % : 0.00% (As of Dec. 13, 2024)

View and export this data going back to . Start your Free Trial

What is Teva Pharmaceutical Industries Dividend Yield %?

As of today (2024-12-13), the Trailing Annual Dividend Yield of Teva Pharmaceutical Industries is 0.00%.

The historical rank and industry rank for Teva Pharmaceutical Industries's Dividend Yield % or its related term are showing as below:

During the past 13 years, the highest Dividend Yield of Teva Pharmaceutical Industries was 9.59%. The lowest was 0.36%. And the median was 2.33%.

FRA:TEV's Dividend Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.855
* Ranked among companies with meaningful Dividend Yield % only.

Teva Pharmaceutical Industries's Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.00.

During the past 13 years, the highest Dividend Payout Ratio of Teva Pharmaceutical Industries was 0.27. The lowest was 0.21. And the median was 0.25.

As of today (2024-12-13), the Forward Dividend Yield % of Teva Pharmaceutical Industries is 0.00%.

Teva Pharmaceutical Industries's Dividends per Share for the three months ended in Sep. 2024 was €0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Teva Pharmaceutical Industries was 73.70% per year. The lowest was -14.10% per year. And the median was 22.90% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Teva Pharmaceutical Industries Dividend Yield % Historical Data

The historical data trend for Teva Pharmaceutical Industries's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries Dividend Yield % Chart

Teva Pharmaceutical Industries Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Yield %

Get a 7-Day Free Trial

Teva Pharmaceutical Industries Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Dividend Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Teva Pharmaceutical Industries's Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Teva Pharmaceutical Industries's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's Dividend Yield % falls into.

Teva Pharmaceutical Industries Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Teva Pharmaceutical Industries (FRA:TEV) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Teva Pharmaceutical Industries Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Teva Pharmaceutical Industries Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (FRA:TEV) » Definitions » Dividend Yield %

Comparable Companies

Traded in Other Exchanges

TEVJF:USA TEVA:USA TEVA:Mexico TEVA:Israel 0LER:UK TEV:Germany TEV:Germany T1EV34:Brazil TEV:Bulgaria TEVA:Austria

Address

124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020

Website

https://www.tevapharm.com

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Teva Pharmaceutical Industries Headlines

No Headlines